Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18–26 years: three-year follow-up data from a randomised clinical trial

National Key Research and Development Plan, the National Natural Science Foundation of China, Beijing Natural Science Foundation, Fundamental Research Funds for the Central Universities, the Fieldwork Funds for graduate students of Xiamen University, and Xiamen Innovax.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Western Pacific
Published
2025-08-27
DOI
https://doi.org/10.1016/j.lanwpc.2025.101671
Citations
2
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18–26 years: three-year follow-up data from a randomised clinical trial

Lingxian Qiu, Ling-Ling Nie, Ting Wu, Li Zhang et al.
2 citations
The Lancet Regional Health - Western Pacific
Cervical Cancer and HPV Research
2.71
article

Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18–26 years: three-year follow-up data from a randomised clinical trial

Lingxian Qiu, Ling-Ling Nie, Ting Wu, Li Zhang, Hongxing Pan, Qiu-Fen Zhang, Kongxin Zhu, Chenxi Nie, Guo‐Hua Zhong, Weijin Huang, Jiali Quan, Ningshao Xia, Jia-Xue Li, Sheng Liu, Kun Li, Lü Chen, Jun Zhang, Jin‐Bo Xu, Kai Chu, Yingying Su, Minglei Zhang, Shoujie Huang, Zhaofeng Bi, Qi Chen
article en
2 citations

Abstract

National Key Research and Development Plan, the National Natural Science Foundation of China, Beijing Natural Science Foundation, Fundamental Research Funds for the Central Universities, the Fieldwork Funds for graduate students of Xiamen University, and Xiamen Innovax.

The Lancet Regional Health - Western PacificVol. 62
Xiamen University (CN), Jiangsu Provincial Center for Disease Control and Prevention (CN), National Institutes for Food and Drug Control (CN)
Openalex Percentile: Top 9%
Cervical Cancer and HPV Research
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18–26 years: three-year follow-up data from a randomised clinical trial — Lingxian Qiu, Ling-Ling Nie, et al. · The Lancet Regional Health - Western Pacific (2025) | TGRS Research Map | TGRS